• Publication & Reference: Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus. Value Health. 2020;23(2):180-90Feb
  • DOI: 10.1016/j.jval.2019.08.012
  • Author(s): Fawsitt CG, Vickerman P, Cooke GS, Welton NJ, Barnes E, Ball J, et al.
Research Theme | Gastrointestinal & Liver

Publication & Reference

Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus. Value Health. 2020;23(2):180-90Feb

DOI

10.1016/j.jval.2019.08.012

Author(s)

Fawsitt CG, Vickerman P, Cooke GS, Welton NJ, Barnes E, Ball J, et al.
Back to all publications

Website by Volute